TKM Ebola (Protiva Biotherapeutics)

N/A

Report date: 2025/08/22 17:57:39
NME

Base Information

Drug NameTKM Ebola (Protiva Biotherapeutics)
Drug Alias NameEbola SNALPTKM-Ebola KikwitsiRNA Ebola virus infection therapeutic (Arbutus Biopharma)TKM-EbolasiEbola-2 +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceAnti-EBOV
TargetsEBOV
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProtiva BiotherapeuticsArbutus Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArbutus Biopharma Corp
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A